HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy.

AbstractUNLABELLED:
Ganglioside GM1, which is particularly abundant in the central nervous system (CNS), is closely associated with the protection against several CNS disorders. However, controversial findings have been reported on the role of GM1 following ischemic stroke. In the present study, using a rat middle cerebral artery occlusion (MCAO) model, we investigated whether GM1 can protect against ischemic brain injury and whether it targets the autophagy pathway. GM1 was delivered to Sprague-Dawley male rats at 3 doses (25 mg/kg, 50 mg/kg, 100 mg/kg) by intraperitoneal injection soon after reperfusion and then once daily for 2 days. The same volume of saline was given as a control. Tat-Beclin-1, a specific autophagy inducer, was administered by intraperitoneal injection at 24 and 48 hours post-MCAO. Infarction volume, mortality and neurological function were assessed at 72 hours after ischemic insult. Immunofluorescence and Western blotting were performed to determine the expression of autophagy-related proteins P62, LC3 and Beclin-1 in the penumbra area. No significant changes in mortality and physiological variables (heart rate, blood glucose levels and arterial blood gases) were observed between the different groups. However, MCAO resulted in enhanced conversion of LC3-I into LC3-II, P62 degradation, high levels of Beclin-1, a large area infarction (26.3±3.6%) and serious neurobehavioral deficits. GM1 (50 mg/kg) treatment significantly reduced the autophagy activation, neurobehavioral dysfunctions, and infarction volume (from 26.3% to 19.5%) without causing significant adverse side effects. However, this biological function could be abolished by Tat-Beclin-1.
IN CONCLUSION:
GM1 demonstrated safe and robust neuroprotective effects that are associated with the inhibition of autophagy following experimental stroke.
AuthorsLi Li, Jinghua Tian, Mitchell King-Wei Long, Yong Chen, Jianfei Lu, Changman Zhou, Tianlong Wang
JournalPloS one (PLoS One) Vol. 11 Issue 1 Pg. e0144219 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID26751695 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apoptosis Regulatory Proteins
  • Beclin-1
  • Becn1 protein, rat
  • Gene Products, tat
  • Heat-Shock Proteins
  • LC3 protein, rat
  • Microtubule-Associated Proteins
  • Neuroprotective Agents
  • Recombinant Fusion Proteins
  • Sequestosome-1 Protein
  • Sqstm1 protein, rat
  • G(M1) Ganglioside
Topics
  • Animals
  • Apoptosis Regulatory Proteins (genetics, metabolism)
  • Autophagy (drug effects)
  • Beclin-1
  • Brain (blood supply, drug effects, metabolism, pathology)
  • Brain Ischemia (drug therapy, genetics, metabolism, pathology)
  • Disease Models, Animal
  • Drug Administration Schedule
  • G(M1) Ganglioside (antagonists & inhibitors, pharmacology)
  • Gene Expression Regulation
  • Gene Products, tat (genetics, metabolism)
  • Heat-Shock Proteins (genetics, metabolism)
  • Infarction, Middle Cerebral Artery (drug therapy, genetics, metabolism, pathology)
  • Injections, Intraperitoneal
  • Male
  • Microtubule-Associated Proteins (genetics, metabolism)
  • Neuroprotective Agents (antagonists & inhibitors, pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Fusion Proteins (genetics, metabolism, pharmacology)
  • Sequestosome-1 Protein
  • Signal Transduction
  • Stroke (drug therapy, genetics, metabolism, pathology)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: